MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$3,303K
Net loss
-$3,303K
Loss before income
taxes
-$3,101K
Provision for income taxes
$202K
Interest income
$123K
Foreign currency gain
(loss)
$8K
Loss from operations
-$3,166K
Australian research and
development incentives
-$56K
Interest expense
$10K
Total operating
expenses
$3,166K
General and
administrative
$1,919K
Research and development
$1,247K
Back
Back
Income Statement
source: myfinsight.com
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)